A multicentred, two-year, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive
E.v. Kesserü, S. Aydinlik, J.J. Etchepareborda, J. KaufmannVolume:
44
Year:
1991
Language:
english
Pages:
599
DOI:
10.1016/0010-7824(91)90079-u
File:
PDF, 645 KB
english, 1991